Chronic fatigue syndrome: An overview

Revista Brasileira de Psiquiatria

Volumn 27, Issue 3, 2005, Pages 174-175

  Cho, Hyong Jin ^a   Wessely, Simon ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOSTEROID; PLACEBO;

ARTHRALGIA; BEHAVIOR THERAPY; CHRONIC FATIGUE SYNDROME; COGNITIVE THERAPY; DISEASE PREDISPOSITION; EDITORIAL; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; HEADACHE; HUMAN; INFECTIOUS MONONUCLEOSIS; KINESIOTHERAPY; LIFESTYLE; MEMORY DISORDER; MOOD DISORDER; MYALGIA; NEUROENDOCRINE SYSTEM; PATHOGENESIS; PSYCHIATRY; PSYCHOLOGICAL ASPECT; SLEEP DISORDER; SOCIAL ASPECT; SYMPTOMATOLOGY; VIRUS INFECTION;

EID: 25144433784     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462005000300003     Document Type: Editorial

References (6)

1. Barsky AJ, Borus JF. Functional somatic syndromes. Ann Intern Med. 1999;130(11):910-21.
2. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet. 1999;354(9182):936-9.
3. Whiting P, Bagnall AM, Sowden AJ, Cornell JE, Mulrow CD, Ramirez G. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA. 2001;286(11):1360-8.
4. Cairns R, Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup Med (Lond). 2005;55(1):20-31.
5. Cho HJ, Hotopf M, Wessely S. The placebo response in the treatment of chronic fatigue syndrome: a systematic review and meta-analysis. Psychosom Med. 2005;67(2):30M3.
6. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001;344(21):1594-602.